Coherus Oncology, Inc. (CHRS)
0.9807
-0.01
(-0.94%)
USD |
NASDAQ |
Oct 19, 13:59
Coherus Oncology Cash from Operations (Annual) : -138.51M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -138.51M |
| December 31, 2024 | -20.44M |
| December 31, 2023 | -174.88M |
| December 31, 2022 | -241.12M |
| December 31, 2021 | -37.43M |
| December 31, 2020 | 154.14M |
| December 31, 2019 | 28.36M |
| Date | Value |
|---|---|
| December 31, 2018 | -159.27M |
| December 31, 2017 | -200.29M |
| December 31, 2016 | -252.54M |
| December 31, 2015 | -107.99M |
| December 31, 2014 | -23.93M |
| December 31, 2013 | 15.42M |
| December 31, 2012 | -18.25M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Enanta Pharmaceuticals, Inc. | -19.27M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |